Skip to content

Fluid Challenge and Plasma Volume, During Surgery

Comparison of Albumin and Ringer's Solution for Optimization of the Plasma Volume and Hemodynamics During Laparoscopic Surgery.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05726136
Acronym
FC-VE
Enrollment
60
Registered
2023-02-13
Start date
2023-10-23
Completion date
2025-10-31
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Urologic Cancer, Gynecologic Cancer, Colorectal Disorders, Benign Neoplasm

Keywords

laparoscopic surgery, fluid therapy, plasma volume

Brief summary

A short bolus infusion of fluid, called fluid challenge is commonly recommended for fluid treatment during longer surgery. However a prolonged increase of the blood volume is a prerequisite to recommend the technique. The purpose with the study is to examine the plasma expanding effect of three different fluid challenge strategies (acetated Ringers 4 ml/kg body weight, albumin 5% 4 ml/kg body weight or albumin 20% 1 ml/kg body weight), using hemoglobin as a dilution indicator.

Detailed description

60 patients scheduled for laparoscopic abdominal surgery, with a duration exceeding 90 minutes will be included in the study. These are randomized to three different groups (20 in each groups): The first group of patients will receive boluses of acetated Ringers 4 ml/kg body weight. The second albumin 4 ml/kg body weight and the third group albumin 20% 1 ml/kg body weight. Hemoglobin, albumin and colloid osmotic pressure (COP) is sampled the day before surgery and in the morning directly prior to the anesthesia. Bioimpedance, urine osmolality and urine-creatinin are also measured. After induction of surgery a Cardio Q probe is inserted threw the nose into the esophagus, for circulatory measurements. Initial/baseline blood samples are taken after insufflation of carbon dioxide to the abdomen. Before every bolus of fluid and 5, (10), 15, 20, 30, 40, (50) and (60) minutes new blood samples are taken for determination of hemoglobin, albumin and COP. Artery blood gases are sampled 15 minutes after every infusion or depending on the clinical need.

Interventions

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first fluid bolus is infused. Circulatory and volume effects are studied. If cardiac output increase a second bolus is infused and studied.

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied.

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied.

Sponsors

Joachim Zdolsek
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

3 randomized parallel groups, with 20 patients in each group. Each group receives a prespecified fluid regime with: 1. acetated Ringers 2. albumin 5% or 3. albumin 20%

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Written consent to participate in the study * For women: relevant contraceptive, menopausal or a negative pregnancy test. * ASA category I to III * Laparoscopic abdominal surgery, with a duration of at least 90 minutes. * 18 to 80 years

Exclusion criteria

* Patients with known cardiac failure * \<18 or \>80 years * known allergy to albumin * extracellular hyperhydration or hypervolemia * kidney failure * pregnancy or planned pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Plasma volume expansion after a fluid bolus60 minutes after an intravenous fluid bolusPlasma volume using hemoglobin as an indicator of dilution

Secondary

MeasureTime frameDescription
Stroke Volume60 minutes after an intravenous fluid bolusChange in stroke volume, measured with Cardio Q (oesophageal Doppler monitoring (ODM))
Arterial Blood Pressure60 minutes after an intravenous fluid bolusMean Arterial Pressure, measured with an arterial line.
Heart Rate60 minutes after an intravenous fluid bolusHeart rate, measured with ECG and pulseoximeter.
Bioimpedance18 to 24 hoursBioimpedance measures, resistance and impedance converted to volume of body fluid compartments.
Fluid Balance18 to 24 hoursCalculations of fluid balance
arterial pH60 minutes after an intravenous fluid bolusInfluence of a fluid bolus on arterial blood gases
arterial Base Excess60 minutes after an intravenous fluid bolusInfluence of a fluid bolus on arterial blood gases
arterial serum sodium60 minutes after an intravenous fluid bolusInfluence of a fluid bolus on Sodium concentration
arterial serum chloride60 minutes after an intravenous fluid bolusInfluence of a fluid bolus on Chloride concentrations
Serum Creatinin18 to 24 hoursSerum Creatinin as a measure of kidney function

Countries

Sweden

Contacts

Primary ContactRobert Svensson, MD
robert.svensson@regionostergotland.se+4610142305
Backup ContactHans Bahlmann, MD, PhD
hans.bahlmann@regionostergotland.se+46101031860

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026